LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 49.33 | 771.67 | 1081 | 6392 | 0.1691 | 0.1168 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 49.33 | 771.67 | 1070 | 6392 | 0.1674 | 0.1131 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 51.55 | 771.67 | 1089 | 6829 | 0.1595 | 0.1157 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 51.55 | 771.67 | 1074 | 6829 | 0.1573 | 0.1108 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.77 | 771.67 | 995 | 7256 | 0.1371 | 0.0818 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.77 | 771.67 | 1048 | 7256 | 0.1444 | 0.0993 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 55.99 | 771.67 | 1127 | 7690 | 0.1466 | 0.1210 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 55.99 | 771.67 | 1052 | 7690 | 0.1368 | 0.0979 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 58.21 | 771.67 | 1131 | 8085 | 0.1399 | 0.1194 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 58.21 | 771.67 | 1012 | 8085 | 0.1252 | 0.0833 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 60.44 | 771.67 | 1019 | 8530 | 0.1195 | 0.0835 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 60.44 | 771.67 | 1005 | 8530 | 0.1178 | 0.0792 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 62.66 | 771.67 | 1104 | 8978 | 0.1230 | 0.1065 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 62.66 | 771.67 | 960 | 8978 | 0.1069 | 0.0636 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 64.88 | 771.67 | 1112 | 9447 | 0.1177 | 0.1064 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 64.88 | 771.67 | 915 | 9447 | 0.0969 | 0.0483 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 67.10 | 771.67 | 1153 | 9800 | 0.1177 | 0.1157 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 67.10 | 771.67 | 881 | 9800 | 0.0899 | 0.0368 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 69.32 | 771.67 | 1237 | 10212 | 0.1211 | 0.1350 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 69.32 | 771.67 | 875 | 10212 | 0.0857 | 0.0343 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 71.54 | 771.67 | 1223 | 10532 | 0.1161 | 0.1299 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 71.54 | 771.67 | 824 | 10532 | 0.0782 | 0.0176 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 73.76 | 771.67 | 1153 | 10851 | 0.1063 | 0.1110 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 73.76 | 771.67 | 788 | 10851 | 0.0726 | 0.0055 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 76.02 | 771.67 | 1276 | 11106 | 0.1149 | 0.1397 | MN20160304_L01 | E14 |